PMV Pharmaceuticals annual total assets
2019
2020
2021
2022
2023
2024
2025
PMV Pharmaceuticals Total Assets Growth & History (PMVP)
PMV Pharmaceuticals's total assets was $116.6M for fiscal 2025.
View full PMV Pharmaceuticals company overviewPMV Pharmaceuticals annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $116.6M | −$74.7M | −39.06% |
| 2024 | 2024-12-31 | $191.3M | −$60.9M | −24.14% |
| 2023 | 2023-12-31 | $252.2M | −$18.2M | −6.72% |
| 2022 | 2022-12-31 | $270.3M | −$61.3M | −18.48% |
| 2021 | 2021-12-31 | $331.6M | −$34.0M | −9.29% |
| 2020 | 2020-12-31 | $365.5M | $262.5M | +254.77% |
| 2019 | 2019-12-31 | $103.0M | — | — |
PMV Pharmaceuticals quarterly total assets
Q4.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $82.1M | −$70.8M | −46.31% |
| Q1 2026 | 2026-03-31 | $96.6M | −$74.0M | −43.40% |
| Q4 2025 | 2025-12-31 | $116.6M | −$74.7M | −39.06% |
| Q3 2025 | 2025-09-30 | $133.8M | −$89.7M | −40.11% |
| Q2 2025 | 2025-06-30 | $152.9M | −$84.7M | −35.65% |
| Q1 2025 | 2025-03-31 | $170.6M | −$66.3M | −27.98% |
| Q4 2024 | 2024-12-31 | $191.3M | −$60.9M | −24.14% |
| Q3 2024 | 2024-09-30 | $223.5M | −$37.5M | −14.38% |
| Q2 2024 | 2024-06-30 | $237.5M | −$4.7M | −1.93% |
| Q1 2024 | 2024-03-31 | $236.9M | −$17.1M | −6.73% |
| Q4 2023 | 2023-12-31 | $252.2M | −$18.2M | −6.72% |
| Q3 2023 | 2023-09-30 | $261.0M | −$24.0M | −8.41% |
| Q2 2023 | 2023-06-30 | $242.2M | −$58.3M | −19.41% |
| Q1 2023 | 2023-03-31 | $254.0M | −$61.0M | −19.38% |
| Q4 2022 | 2022-12-31 | $270.3M | −$61.3M | −18.48% |
| Q3 2022 | 2022-09-30 | $285.0M | −$59.2M | −17.20% |
| Q2 2022 | 2022-06-30 | $300.6M | −$55.3M | −15.55% |
| Q1 2022 | 2022-03-31 | $315.0M | −$39.4M | −11.11% |
| Q4 2021 | 2021-12-31 | $331.6M | −$34.0M | −9.29% |
| Q3 2021 | 2021-09-30 | $344.2M | −$30.3M | −8.08% |
| Q2 2021 | 2021-06-30 | $355.9M | — | — |
| Q1 2021 | 2021-03-31 | $354.4M | — | — |
| Q4 2020 | 2020-12-31 | $365.5M | $262.5M | +254.77% |
| Q3 2020 | 2020-09-30 | $374.4M | — | — |
| Q4 2019 | 2019-12-31 | $103.0M | — | — |
PMV Pharmaceuticals total assets trends
Over the last five fiscal years, PMV Pharmaceuticals's total assets decreased from $365.5M to $116.6M, a change of −$249.0M. The latest reported quarter, Q2 2026, shows $82.1M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review PMV Pharmaceuticals source filings ↗